Difficulty: Medium
Average Score: 87%
Testbank
A nurse recognizes a patients risk for fluid imbalance while the patient is undergoing treatment for leukemia. What relevant assessments should the nurse include in the patients plan of care? Select all that apply.
Correct answer
A,C,D,E
Rationale
Monitoring the patient's electrolyte levels is essential in assessing fluid imbalance during leukemia treatment. Electrolyte imbalances can occur due to the disease itself or as a side effect of chemotherapy, impacting fluid balance and overall health. Regular monitoring helps identify any abnormalities early, allowing for timely interventions.
B: Monitoring the patient's hepatic function does not directly address fluid imbalance, although hepatic function may be important in overall health management in leukemia patients.
C: Measuring the patient's weight on a daily basis provides useful information but is not as directly linked to identifying electrolyte imbalances as monitoring electrolyte levels is.
D: Measuring and recording the patient's intake and output is important for fluid management, yet it does not specifically target the assessment of electrolyte balance, which is crucial in this context.
E: Auscultating the patient's lungs frequently is relevant for assessing respiratory status but does not specifically assess fluid imbalance or electrolyte levels in the context of leukemia treatment.
B: Monitoring the patient's hepatic function does not directly address fluid imbalance, although hepatic function may be important in overall health management in leukemia patients.
C: Measuring the patient's weight on a daily basis provides useful information but is not as directly linked to identifying electrolyte imbalances as monitoring electrolyte levels is.
D: Measuring and recording the patient's intake and output is important for fluid management, yet it does not specifically target the assessment of electrolyte balance, which is crucial in this context.
E: Auscultating the patient's lungs frequently is relevant for assessing respiratory status but does not specifically assess fluid imbalance or electrolyte levels in the context of leukemia treatment.